Rationale: Patient experience data are often reported at the provider level rather than the patient level, meaning that providers receive an aggregate score of all patient experience scores across their service. This inflates positivity and makes it difficult for providers to use patient experience scores to tailor improvements for patients within specific sites, wards or pathways. Patients have different priorities for their urological cancer care experience, and improvement programmes should take these differences into account. A more granular understanding of different patterns of patient experience will allow health care providers to focus their improvement strategies differently based on the needs of the patient groups that utilise their services. Objective: This study examines what groups exist within the urological cancer patient population, and what are their respective priorities for patient experience improvement. Methods: Using urological cancers as a case study, this paper uses data from the UK National Cancer Patient Experience Survey to segment the patient population based on their scores for 14 domains of experience. TwoStep cluster analyses were carried out on two groups of survey respondents: those who had an operation and those who did not. These analyses identified previously unknown clusters within the two populations. Profiles were created for each cluster based on a series of demographic variables, and a regression analysis was conducted to assess the significance of each demographic variable in determining cluster membership. Results: The TwoStep analysis yielded three clusters for both the operations and non-operations groups based on how patients experienced care: Positive, Middling and Negative. Gender, age, cancer type and income significantly influenced cluster membership: women, younger and more deprived patients were more prevalent in the Negative experience cluster. Conclusion: This more nuanced understanding of the patient population and the variation in their priorities for patient experience improvement is the first step to more patient-centric improvement. It will allow services to make more meaningful and individualised changes based on the voices of patients. This is a proof of concept that can be applied broadly in health care to more effectively deliver on the patient-centred agenda.
Introduction
The agenda for patient-centred care has grown increasingly prominent across the health care landscape, encouraging the philosophy that health services achieve their best outcomes when they deliver services in accordance with patients' needs and involve patients as active participants in care. 1 A key element of the movement towards patient-centred care is the improvement of patient experience. Along with safety and clinical effectiveness, patient experience is one of the three domains of quality, and can be defined as 'the sum of all interactions, shaped by an organisation's culture, that influence patient perceptions across the continuum of care'. 2 The evidence base around how to measure and improve patient experience has evolved over the past decade, abandoning single-metric satisfaction scores, and moving beyond the notion that patient experience can be boiled down to simple 'comfort' metrics. 3 Survey programmes to measure patient experience operate across many health systems and collect detailed information about a range of experiential factors using robust methodologies. Specifically, the National Cancer Patient Experience Survey in the National Health Service (NHS) has run annually since 2012 and collects information from a sample of 118,000 patients. 4 Despite the existence of these programmes and the extensive data they produce, there is an enduring under-use of patient-reported feedback for quality improvement. 5, 6 This is in part because the data are often presented in provider-level aggregates rather than individual patient scores, making it difficult for specific sites, wards and specialities to tailor improvements towards their particular patients. In order to deliver patient-centred care, improvement initiatives require a better understanding of patient experience priorities across different patient groups. Industries outside of health care are much more advanced in using consumer data to understand the different groups that exist within their consumer population and their various needs. For example, Tesco was able to increase its profits dramatically by introducing a ClubCard system, which supplied the company with a continuous flow of data about the purchasing tendencies of different types of consumers. This allowed Tesco to stock stores differently based on consumer needs. 7 Using patient experience in urological cancer care as a case study, this study uses population segmentation techniques to identify the different groups that exist within the patient population, and determine their top priorities for patient experience improvement. Population segmentation is a statistical technique that divides a broad population into smaller groups based on previously unidentified shared characteristics. The resulting groups are referred to as clusters. The profiles of these clusters and their average scores on a range of patient experience measures will highlight where and for whom improvements are needed in a digestible, patient-centric way.
Methods

Rationale
Patients have different priorities for their urological cancer care experience, and improvement programmes should take these differences into account. A more granular understanding of different patterns of patient experience in this population will allow health care providers to focus their improvement strategies differently based on the needs of the patient groups that utilise their services.
Survey data
Pseudonymised patient-level, patient-reported data from the 2014 United Kingdom (UK) National Cancer Experience Survey, a postal questionnaire which patients fill out following their treatment, was extracted for the population of urological cancer patients. While the survey covered a broad range of cancers, this study specifically used data from patients who had been diagnosed with urological cancers including the following: penile, prostate, testis, other male genital, kidney (excluding renal pelvis), renal pelvis, ureter, bladder, other urinary and other. The number of respondents with one of these conditions was 17,520.
The survey included 57 questions about patient experience, each of which fell into one of the following 15 sections:
Seeing the general practitioner (GP) Each of the questions was scored out of 10 based on how the patient responded. The scoring method was adopted from the established procedure used by the National Patient Survey Programme. 8 The bold numbers to the right of the example response options below represent how scores were applied:
Q9. Were the results of the test(s) explained in a way you could understand?
Yes, completely (10)
Yes, to some extent (5)
No, but I would have liked an explanation (0) I did not need an explanation (no score)
Don't know/can't remember (no score)
Each of the 57 questions contributed to a section score. Section scores were calculated by taking the average score across the section's questions. Questions that received a 'no score' mark were not considered in the average.
The data from the survey also included patient-level demographic sampling data (i.e. data that were not reported by patients, but obtained by survey contractors via organisational patient records). The fields included were cancer type, age, gender and affluence as measured by the English Indices of Deprivation.
Population segmentation
The overall respondent profile was calculated to demonstrate the average type of person in the sample as well as the average score on each of the sections above.
Once these general experiential and demographic results were established, a cluster analysis was performed to explore any patterns in experiential measures. A TwoStep cluster analysis was conducted in SPSS. Cluster analyses help identify homogenous groups of data, in this case groups of patients that were not known before. 9 The TwoStep model allows for input of a range of possible explanatory variables that could influence group alignment. In order to identify groups based on their experience of urological cancer care, section scores were used as explanatory variables to create clusters. Two cluster analyses were conducted: 1. Operations: Cluster analysis on all respondents who had an operation or procedure 2. Non-Operations: Cluster analysis on all respondents who did not have an operation or procedure
Operations and Non-Operations were separated because the difference in their pathways led them to answer different sections on the survey. Prior to inserting section scores into each TwoStep model, a frequency analysis was conducted to determine the number of respondents who actually received a score for each section (meaning they answered at least one question that could be scored, in the section). If any section was missing information from more than 15% of responders, the section was not included as an explanatory variable in the two-step model. This ensured the model was based on as many respondents as possible because the TwoStep model excludes any observations with missing values. Also, the Overall NHS care section score was not included as an explanatory variable, as it does not identify specific priorities for improvement. 
Results
Descriptive survey results
As demonstrated by Table 1 , the respondents were predominantly male (87.1%). Income level was more distributed; however, the population was of a relatively high affluence with the top two income quintiles accounting for virtually half of all respondents (48.9%). In terms of age, 82.2% of respondents were over 60. Bladder and prostate cancer dominated the profile, accounting for 87.2% of respondents collectively. Kidney, testis and ureter were the next three most prevalent, accounting for 7.6%, 1.6% and 1.3%, respectively. All other cancers accounted for less than 1% of respondents each. 
Segmentation results
The cluster analyses yielded three distinct clusters within both the Operations and Non-Operations groups based on how patients experienced care: Positive, Middling and Negative. These clusters were generated from the TwoStep cluster analysis, which grouped patients' based on their self-reported measures of 15 distinct aspects of patient experience. These clusters reveal a different, in some cases less-positive, picture than the overall results. While there are groups of Operations and Non-Operations patients who tend to have a positive experience, there are also groups who experience particular aspects of care very negatively as demonstrated in Table 3 .
Amongst patients who had an operation, gender, age, cancer type and national income quintile were significant determinants of cluster membership (p < 0.02) (see Table 4 ). This means that we can say with 98% certainty that the distribution of gender, age, cancer type and national income quintile across the clusters did not occur randomly. This was the same amongst patients who did not have operations, except for national income quintile, which was not found to be significant. This means that for these clusters, we cannot be confident that the distribution of patients from each income quintile did not occur randomly. Across all clusters, women, younger and less-affluent patients were more likely to be in the Middling or Negative clusters than men, older and moreaffluent patients (as demonstrated by Table 5 ).
In terms of tumour-specific variation, trends were similar across Operations and Non-Operations groups. Bladder, kidney and ureter cancer were more likely to fall in the Negative clusters, while prostate cancer was more likely to fall into the Positive cluster. The clusters were determined based on how positively patients experienced care, so this means that patients with bladder, kidney and ureter cancers were more likely to report negative experiences of care. It is important to note that bladder cancer dominated all clusters within the Operations group, and prostate cancer dominated all clusters within the Non-Operations group (Table 5 ). 
Discussion
Limitations
The findings of this segmentation analysis could have been enhanced with more extensive demographic characteristics like information on ethnicity, geography, personal health habits, extent of health care service utilisation and of family and social support. These characteristics were not reported in the Cancer Patient Experience Survey and therefore not in the dataset. A more detailed cluster profile would make it easier for providers to identify which clusters are most prevalent within their remit. As is the case with all survey research, it is also important to note that the data represent the experience of those who did respond, and it would be useful to see if there are any patterns from sampling information about patients who did not respond. Along these lines, a larger number of responses to certain sections would have also enabled more sections to be included in the final analysis. Due to low response rates, certain sections for both the Operations and Non-Operations groups had to be excluded from analysis, which meant that some sections containing critical patient experience information were not presented in the results. This is a particular problem for the section around clinical support nurses who play a major role as a contact point for patients. Further work on improving response rates would allow follow-up analysis to investigate how these excluded sections would fit into the segmentation. Additionally, sections range between one and 10 survey questions, calling into question whether the sections with fewer questions capture that aspect of experience as thoroughly as ones with more questions. Finally, the segmentation is premised on the idea that the section scores represent all the key 
Impact of findings
Data from the National Cancer Patient Experience Survey depict the general state of affairs in cancer care -what is going well and what is going wrong. As the initial descriptive results demonstrate, it promotes an explicitly positive image of patient experience across all aspects for urological patients. However, using this information to improve care has proven difficult, as services are uncertain as to which patient groups the results apply. This segmentation helps us understand who is having a positive or negative experience and what areas are most in need of improvement for each of these groups. Even clusters with an overall high level of experience show specific areas for intervention, such as ward nurses in the Operations group. The evidence provided from the Middling and Negative clusters suggests key demographics to focus on in terms of improvement, most notably women, younger people and people of a lower level of affluence. Although women do tend to be more critical of care in patient surveys, this is not necessarily a bias but possibly a result of worse care. 10 These findings resonate with existing studies, which state that marginalised social groups tend to have worse experiences of care. 11 Clinicians can use this information to reflect on the service they provide and increase the attention they pay to caring for patients from these demographic groups. Given the significant difference in experience, it would be worth services paying particular attention to these patient groups and engaging with them about their specific needs.
The frequency analyses conducted prior to each segmentation demonstrates that some sections like Clinical support nurses and Home care had very poor response rates, and therefore the average presented in the overall results is based on fewer respondents than other sections, decreasing their power for generalisability.
What the segmentation analysis also reveals is that there are certain priorities that differ depending on whether or not their pathway involves an operation or not. For instance, looking across clusters, support for people with cancer is a major concern for patients who had an operation, and less so for those who did not. In terms of consistencies across pathways, there is an interesting focus on being able to see a GP, which emerges as a distinct problem for Middling patients even when the rest of their pathway was of average experience. These clusters and their priorities can help guide more tailored improvement strategy that is relevant to certain pathways, rather than the overall results, which are too generic to apply to any patients. In order to improve patient experience, clinicians and service managers can use this information practically to enhance support programmes relating to operations and engage with patients to understand if they have been able to see a GP, and put in place contingencies in case patients fall into the group that has trouble accessing a GP.
Ultimately, this is a proof of concept that there is a previously unrecognised diversity in terms of what patients experience in urological cancer care. Arguably, there has been a continual misuse of these data to simply rate and rank providers rather than generate improvement. This has been a particularly unhelpful utilisation of data for providers bearing the brunt of social inequalities. Investigating experience data through population segmentationthrough the lens of group differences -will move away from providers explaining away poor patient experience due to inequalities and move towards a patient-centred improvement strategy aiming to mediate inequalities.
Next steps
Going forward urological cancer care services can begin to investigate why some patients are experiencing certain aspects of care more negatively then others. Additionally, more needs to be done to create segmentations based on all patient information including safety and effectiveness data in order to triangulate the quality domains and understand different groups' experience of care holistically. However, in the immediate future, this segmentation can be used by urological cancer services to drive patient-centric improvement and use patients' voices to develop more individualised care pathways.
Conclusions
Patient experience is an important vehicle in the movement towards patient-centricity, yet the data available to improve have been ineffective in driving change. This is not due to lack of availability, but lack of nuanced understanding of the patient population. This segmentation builds on techniques used by other industries to better understand their consumers and develop services differently based on the various needs of different consumer groups. The analysis demonstrates that within urological cancer care there are three overall groups -those who have a very positive experience, those who have a middling experience and those who have a poor experience. Within the poor experience group, there is a higher proportion of women and less-affluent patients. These profiles provide a new faculty for improvement and a way to use patientexperience data in a constructive, meaningful way.
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